News
1d
News Medical on MSNBuilding Bridges to Scalable Allogeneic Cell TherapyRui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...
Thus, myogenic progenitors might be a promising candidate as seed cells ... Erythrocytes were removed by red blood cell lysis buffer (Thermo Fisher Scientific, cat# 00-433-57). The single-cell ...
A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...
The variety of blood cells decreases with age. Some are lost, while others become dominant, leading to a loss of functional ...
Quite often, blood cancer patients require the replacement of their blood stem cells in the bone marrow, the tissue producing ...
3d
News-Medical.Net on MSNBlood cell-free RNA signatures can predict preterm birth months in advanceChildren born before 37 weeks of gestation have a considerably increased risk of dying before they reach the age of five.
Federally funded Johns Hopkins team finds the virus ‘reprograms’ neutrophils to impair production of immune cells critical ...
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach ...
They created the fragments from scratch and dropped them into mouse blood cells, where the sequence fused with the genome at random locations. The experiments worked exactly as predicted and pave ...
The model can be told to create synthetic fragments of DNA with custom criteria, for example, "switch this gene on in stem cells which will turn into red-blood-cells but not platelets." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results